DIA 2nd Annual Clinical Forum: Data Driven Drug Development Decisions

Share Article

Following a very successful first event in 2007, the Drug Information Association's (DIA's) 2nd Annual Clinical Forum: Data Driven Drug Development Decisions (October 20-23, 2008; Ljubljana, Slovenia) will focus on clinical data.

The 2nd Annual Clinical Forum will incorporate nearly 20 years of industry-renowned DIA CDM Conferences, as well as many years of groundbreaking DIA eClinical, Clinical Research, Validation and IT conferences

Following a very successful first event in 2007, the Drug Information Association's (DIA's) 2nd Annual Clinical Forum: Data Driven Drug Development Decisions (October 20-23, 2008; Ljubljana, Slovenia) will focus on clinical data. New and experienced colleagues in the field of clinical and safety data management, clinical research and operations, statistics, medical information, pharmacovigilance, information technology and validation will be able to attend a wide range of educational forums, discuss experiences and uncover solutions.

In addition to established formats like tutorials and sessions dedicated to the different areas of interest, cross-functional workshops looking at a particular operations topic from different angles will provide the opportunity to meet colleagues from business partner functions to discuss new ideas, interfaces and data streams.

"The 2nd Annual Clinical Forum will incorporate nearly 20 years of industry-renowned DIA CDM Conferences, as well as many years of groundbreaking DIA eClinical, Clinical Research, Validation and IT conferences," says Programme Chair Jens Reinhold, Head of Non-Interventional Studies, Bayer Schering Pharma AG, Germany. "This year, following a very successful first event in 2007 that attracted 700+ delegates from over 20 countries, the DIA Clinical Forum will again provide broad learning, robust discussion and networking opportunities for clinical research professionals."

A special addition to this year's event, ''This House Believes that 90% of all Data Collected is Rubbish,'' will feature four debaters who will present their arguments on the topic of data collection during clinical trials and the value it does or does not add. Audience members will have an opportunity to vote at the beginning and end of the debate, listen to seasoned professionals provide arguments for both sides and ask questions of the debaters.

Also, Thursday workshops will provide expert knowledge from patients, regulators, physicians and industry specialists on topics such as:

  • The Changing Landscape of Non-Interventional Studies (NIS) in the Current International Regulatory Framework
  • Finding the Right Balance in Research Protection
  • Future of Personalised Medicines
  • Professional Education and Career in Drug Development

More than 50 exhibitors will display their products or services to a global audience of qualified professionals from over 30 countries, from entry level to expert, in the pharmaceutical, biotechnology and related industries, government, academia and healthcare delivery. The exhibition hall will be open from Tuesday, October 21 until Thursday, October 23.

About the Drug Information Association (DIA)

DIA serves more than 30,000 professionals in the biotechnology, pharmaceutical and regulatory industries worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, and Mumbai, India, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit http://www.diahome.org or call 215-442-6100.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Joe Krasowski
Visit website